StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Trading Down 1.7 % Cumberland Pharmaceuticals stock opened at $1.48 on Friday. The company has a debt-to-equity ratio of 0.59, […]